Literature DB >> 32190638

Late-onset multiple acyl-CoA dehydrogenase deficiency with cardiac syncope: A case report.

Xue-Qi Pan1, Xue-Li Chang1, Wei Zhang1, Hua-Xing Meng1, Jing Zhang1, Jia-Ying Shi1, Jun-Hong Guo2.   

Abstract

BACKGROUND: Multiple acyl-CoA dehydrogenase deficiency (MADD) is an uncommon autosomal recessive disorder of mitochondrial fatty acid beta-oxidation. Syncope is a transient loss of consciousness due to acute global cerebral hypoperfusion. Late-onset MADD with syncope has not been reported previously. CASE
SUMMARY: We report a 17-year-old girl with exercise intolerance and muscle weakness. She felt palpitation and shortness of breath after short bouts of exercise. She also suffered from a transient loss of consciousness many times. Muscle biopsy showed lipid storage. Genetic mutation analysis indicated a compound heterozygous mutation c.250G > A (p.A84T) and c.872T > G (p.V291G) in the ETFDH gene. The results of Holter electrocardiogram monitoring showed supraventricular tachycardia when the patient experienced a loss of consciousness. After treatment with riboflavin and carnitine, muscle weakness and palpitation symptoms improved rapidly. No loss of consciousness occurred, and the Holter electrocardiogram monitoring was normal.
CONCLUSION: Late-onset MADD with supraventricular tachycardia can cause cardiac syncope. Carnitine and riboflavin supplement were beneficial for treating the late-onset MADD with cardiac syncope. Attention should be paid to the prevention of cardiac syncope when diagnosing late-onset MADD. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Cardiac syncope; Carnitine; Case report; ETFDH; Late-onset multiple acyl-CoA dehydrogenase deficiency; Mitochondrion; Supraventricular tachycardia

Year:  2020        PMID: 32190638      PMCID: PMC7062611          DOI: 10.12998/wjcc.v8.i5.995

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  23 in total

Review 1.  Lipid storage myopathies: Current treatments and future directions.

Authors:  Emily R Vasiljevski; Matthew A Summers; David G Little; Aaron Schindeler
Journal:  Prog Lipid Res       Date:  2018-08-09       Impact factor: 16.195

2.  Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.

Authors:  Jianying Xi; Bing Wen; Jie Lin; Wenhua Zhu; Sushan Luo; Chongbo Zhao; Duoling Li; Pengfei Lin; Jiahong Lu; Chuanzhu Yan
Journal:  J Inherit Metab Dis       Date:  2013-12-20       Impact factor: 4.982

3.  An intronic variation in SLC52A1 causes exon skipping and transient riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency.

Authors:  Signe Mosegaard; Gitte Hoffmann Bruun; Karen Freund Flyvbjerg; Yngve Thomas Bliksrud; Niels Gregersen; Maja Dembic; Ellen Annexstad; Trine Tangeraas; Rikke Katrine Jentoft Olsen; Brage S Andresen
Journal:  Mol Genet Metab       Date:  2017-11-02       Impact factor: 4.797

4.  Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.

Authors:  D Bonnet; D Martin; E Villain; P Jouvet; D Rabier; M Brivet; J M Saudubray
Journal:  Circulation       Date:  1999-11-30       Impact factor: 29.690

5.  High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late-onset lipid storage myopathy.

Authors:  M-Y Lan; M-H Fu; Y-F Liu; C-C Huang; Y-Y Chang; J-S Liu; C-H Peng; S-S Chen
Journal:  Clin Genet       Date:  2010-12       Impact factor: 4.438

6.  Heterogeneous Phenotypes in Lipid Storage Myopathy Due to ETFDH Gene Mutations.

Authors:  Corrado Angelini; Daniela Tavian; Sara Missaglia
Journal:  JIMD Rep       Date:  2017-04-30

7.  Cardiac and skeletal myopathy associated with cardiac dysrhythmias.

Authors:  A Dunnigan; M E Pierpont; S A Smith; G Breningstall; D G Benditt; D W Benson
Journal:  Am J Cardiol       Date:  1984-03-01       Impact factor: 2.778

8.  Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency.

Authors:  Rikke K J Olsen; Brage S Andresen; Ernst Christensen; Peter Bross; Flemming Skovby; Niels Gregersen
Journal:  Hum Mutat       Date:  2003-07       Impact factor: 4.878

Review 9.  l-Carnitine and heart disease.

Authors:  Zhong-Yu Wang; Ying-Yi Liu; Guo-Hui Liu; Hai-Bin Lu; Cui-Ying Mao
Journal:  Life Sci       Date:  2017-12-11       Impact factor: 5.037

10.  Mitochondrial dysfunction in human skeletal muscle biopsies of lipid storage disorder.

Authors:  Bandopadhyay Debashree; Manish Kumar; Thottethodi Subrahmanya Keshava Prasad; Archana Natarajan; Rita Christopher; Atchayaram Nalini; Parayil Sankaran Bindu; Narayanappa Gayathri; Muchukunte Mukunda Srinivas Bharath
Journal:  J Neurochem       Date:  2018-04-19       Impact factor: 5.372

View more
  2 in total

1.  Screening of multiple acyl-CoA dehydrogenase deficiency in newborns and follow-up of patients.

Authors:  Duo Zhou; Meiling Ye; Zhenzhen Hu; Yu Zhang; Lin Zhu; Rulai Yang; Xinwen Huang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-25

2.  Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review.

Authors:  Maria Anna Siano; Claudia Mandato; Lucia Nazzaro; Gennaro Iannicelli; Gian Paolo Ciccarelli; Ferdinando Barretta; Cristina Mazzaccara; Margherita Ruoppolo; Giulia Frisso; Carlo Baldi; Salvatore Tartaglione; Francesco Di Salle; Daniela Melis; Pietro Vajro
Journal:  Front Pediatr       Date:  2021-05-10       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.